These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11522442)

  • 1. Proteasomes and proteasome inhibition in the central nervous system.
    Ding Q; Keller JN
    Free Radic Biol Med; 2001 Sep; 31(5):574-84. PubMed ID: 11522442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proteasome in brain aging.
    Keller JN; Gee J; Ding Q
    Ageing Res Rev; 2002 Apr; 1(2):279-93. PubMed ID: 12039443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 20S proteasome mediated degradation of DHFR: implications in neurodegenerative disorders.
    Amici M; Sagratini D; Pettinari A; Pucciarelli S; Angeletti M; Eleuteri AM
    Arch Biochem Biophys; 2004 Feb; 422(2):168-74. PubMed ID: 14759604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chronic low-level proteasome inhibition on neural homeostasis.
    Ding Q; Dimayuga E; Martin S; Bruce-Keller AJ; Nukala V; Cuervo AM; Keller JN
    J Neurochem; 2003 Jul; 86(2):489-97. PubMed ID: 12871590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine induces proteasome inhibition in neural PC12 cell line.
    Keller JN; Huang FF; Dimayuga ER; Maragos WF
    Free Radic Biol Med; 2000 Nov; 29(10):1037-42. PubMed ID: 11084292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA antagonists exacerbate neuronal death caused by proteasome inhibition in cultured cortical and striatal neurons.
    Snider BJ; Tee LY; Canzoniero LM; Babcock DJ; Choi DW
    Eur J Neurosci; 2002 Feb; 15(3):419-28. PubMed ID: 11876769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.
    Dou QP; Smith DM; Daniel KG; Kazi A
    Prog Cell Cycle Res; 2003; 5():441-6. PubMed ID: 14593738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy.
    Wojcik C; Di Napoli M
    Stroke; 2004 Jun; 35(6):1506-18. PubMed ID: 15118168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of geranylgeranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons.
    Kikuchi S; Shinpo K; Takeuchi M; Tsuji S; Yabe I; Niino M; Tashiro K
    J Neurosci Res; 2002 Aug; 69(3):373-81. PubMed ID: 12125078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.
    Höglinger GU; Carrard G; Michel PP; Medja F; Lombès A; Ruberg M; Friguet B; Hirsch EC
    J Neurochem; 2003 Sep; 86(5):1297-307. PubMed ID: 12911637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins.
    Ding Q; Keller JN
    J Neurochem; 2001 May; 77(4):1010-7. PubMed ID: 11359866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome activation and nNOS down-regulation in neuroblastoma cells expressing a Cu,Zn superoxide dismutase mutant involved in familial ALS.
    Aquilano K; Rotilio G; Ciriolo MR
    J Neurochem; 2003 Jun; 85(5):1324-35. PubMed ID: 12753090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared.
    Bardag-Gorce F; Venkatesh R; Li J; French BA; French SW
    Life Sci; 2004 Jun; 75(5):585-97. PubMed ID: 15158368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress.
    Ding Q; Reinacker K; Dimayuga E; Nukala V; Drake J; Butterfield DA; Dunn JC; Martin S; Bruce-Keller AJ; Keller JN
    FEBS Lett; 2003 Jul; 546(2-3):228-32. PubMed ID: 12832045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress.
    Fataccioli V; Andraud E; Gentil M; French SW; Rouach H
    Hepatology; 1999 Jan; 29(1):14-20. PubMed ID: 9862843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does proteasome inhibition play a role in mediating neuropathology and neuron death in Alzheimer's disease?
    Ding Q; Keller JN
    J Alzheimers Dis; 2003 Jun; 5(3):241-5. PubMed ID: 12897408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of proteasome activity and proteasome expression in aging spinal cord.
    Keller JN; Huang FF; Markesbery WR
    Neuroscience; 2000; 98(1):149-56. PubMed ID: 10858621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAc modification is an endogenous inhibitor of the proteasome.
    Zhang F; Su K; Yang X; Bowe DB; Paterson AJ; Kudlow JE
    Cell; 2003 Dec; 115(6):715-25. PubMed ID: 14675536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracellular localization of the proteasome.
    Gordon C
    Curr Top Microbiol Immunol; 2002; 268():175-84. PubMed ID: 12083005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.